Page last updated: 2024-10-27

fluconazole and Iris Neoplasms

fluconazole has been researched along with Iris Neoplasms in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Iris Neoplasms: Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shi, T1
Wu, L1
Cai, J1
Chen, H1

Other Studies

1 other study available for fluconazole and Iris Neoplasms

ArticleYear
An Iris Tumor Secondary to
    Ocular immunology and inflammation, 2022, Volume: 30, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Fluconazole; Humans; Iris Neoplasms; M

2022